Direct Oral Anticoagulants (DOACs)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Direct Oral Anticoagulants (DOACs) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Direct Oral Anticoagulants (DOACs) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Lower limb trauma requiring immobilization is a very frequent condition that is associated with an increased risk of developing venous thromboembolism (VTE). Th…
Older people falling from a standing height is the most common cause of hospital admission for head injury. Up to 1 in 3 patients admitted are taking a tablet m…
Venous thromboembolism (VTE) and atherosclerotic cardiovascular disease share common risk factors and frequently coexist in the same patients. Their management…
This registry, currently being established will ensure consistency of data collection and provide safety information in non high-risk APS patients currently on…
End-stage renal disease (ESRD) is a growing global health burden, and the creation of a native arteriovenous fistula (AVF) is the gold standard for vascular acc…
The clinical benefit of pill-in-the-POCKET anticoagulation after atrial fibrillation catheter ablation remains uncertain. We aimed to evaluate the clinical bene…
This is a multicentre, prospective, randomised, double-blinded, group-sequential, parallel-group, adaptive design, phase 3 study to demonstrate the haemostatic…
The objective of this study was to investigate whether there is a link between clinical and biological variables and bioassay high xaban in elderly patients as…